Product Information
IBUPROFEN 800 MG TABLET is a generic product labeled by Time-Cap Labs Inc., priced at $0.0573 per EA under NDC 49483060401. Its NADAC has been published 542 times since May 18, 2016.
FDA first approved this application on Dec 21, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
800 mg/1
Manufacturer
Time-Cap Labs Inc.NDC
49483060401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA090796FDA Approved
12/21/2010
TE Code
AB
On Market Since
12/30/2015
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 800 MG TABLET has been published 542 times since May 18, 2016, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0573 per EA |
|---|---|
| All-time high | $0.0933 (Mar 11, 2020) |
| All-time low | $0.0483 (Dec 20, 2017) |
| 52-week high | $0.0587 |
| 52-week low | $0.0549 |
| Median price | $0.0649 |
| Average price | $0.0664 |
| Largest weekly change | -20.3% (Apr 17, 2024) |
| Weeks tracked | 542 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Time-Cap Labs Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IBUPROFEN 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 800 MG TABLET, manufactured by Time-Cap Labs Inc., is $0.0573 per EA (NDC 49483060401), effective Sep 30, 2026.
How has the price of IBUPROFEN 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 800 MG TABLET has held within roughly two percent of its current level. It has been tracked across 542 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 800 MG TABLET?
Since May 18, 2016, the NADAC for IBUPROFEN 800 MG TABLET has ranged from a low of $0.0483 (Dec 20, 2017) to a high of $0.0933 (Mar 11, 2020), with a median of $0.0649 per EA.
Are there cheaper alternatives to IBUPROFEN 800 MG TABLET?
Yes. 15 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 800 MG TABLET, is $0.0567 per EA — about 1% below IBUPROFEN 800 MG TABLET.
Who manufactures IBUPROFEN 800 MG TABLET?
IBUPROFEN 800 MG TABLET (NDC 49483060401) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.